Wealth Enhancement Advisory Services LLC Boosts Holdings in HCA Healthcare, Inc. $HCA

Wealth Enhancement Advisory Services LLC increased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 3.6% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 157,188 shares of the company’s stock after purchasing an additional 5,486 shares during the quarter. Wealth Enhancement Advisory Services LLC owned 0.07% of HCA Healthcare worth $68,781,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Hemington Wealth Management boosted its position in HCA Healthcare by 11.0% during the 3rd quarter. Hemington Wealth Management now owns 253 shares of the company’s stock valued at $107,000 after buying an additional 25 shares during the period. Abound Wealth Management grew its stake in shares of HCA Healthcare by 28.0% in the third quarter. Abound Wealth Management now owns 119 shares of the company’s stock worth $51,000 after purchasing an additional 26 shares during the last quarter. ORG Partners LLC lifted its holdings in HCA Healthcare by 27.9% in the 2nd quarter. ORG Partners LLC now owns 142 shares of the company’s stock worth $55,000 after buying an additional 31 shares during the period. Optas LLC raised its holdings in shares of HCA Healthcare by 4.5% during the third quarter. Optas LLC now owns 760 shares of the company’s stock valued at $324,000 after acquiring an additional 33 shares in the last quarter. Finally, Sivia Capital Partners LLC raised its holdings in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 1.2%

NYSE HCA traded down $5.74 during trading hours on Tuesday, hitting $463.55. 145,554 shares of the company’s stock traded hands, compared to its average volume of 891,746. The business’s fifty day moving average price is $480.68 and its two-hundred day moving average price is $431.78. HCA Healthcare, Inc. has a 52 week low of $295.00 and a 52 week high of $520.00. The firm has a market capitalization of $105.78 billion, a P/E ratio of 17.89, a P/E/G ratio of 1.29 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The business had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were paid a dividend of $0.72 per share. The ex-dividend date of this dividend was Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is currently 11.13%.

Analysts Set New Price Targets

Several analysts have commented on the stock. Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price objective for the company. in a report on Monday, December 15th. Mizuho increased their price objective on HCA Healthcare from $505.00 to $520.00 and gave the stock an “outperform” rating in a report on Thursday, December 18th. Cowen reissued a “buy” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Robert W. Baird upped their price target on HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Finally, UBS Group raised their price target on HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a report on Monday, October 27th. Fifteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $487.00.

Insider Activity

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This represents a 52.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.